Skip to main content

Table 2 Induction of different cytochrome P450 isoenzymes in cultured human hepatocytes from five different donors with Helixor® A (HA), Helixor® M (HM) and Helixor® P (HP). Fold induction of activity over respective negative control (incubation with no test item) is given. Test mixtures containing reference inducers were used as positive controls (PC)

From: Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities

CYP

CYP1A2

CYP2B6

CYP2C9

CYP2E1

CYP3A4

Donor

D1

D2

D3

D1

D4

D5

D1

D4

D5

D1

D2

D3

D1

D2

D3

PC

19.2

21.8

31.6

3.0

3.7

2.9

1.5

1.3

1.5

1.2

1.0

1.0

1.7

1.9

3.3

HA 10 μg/ml

0.5

0.8

0.4

1.0

0.6

1.2

0.6

0.6

0.4

0.9

0.6

0.8

1.0

0.7

0.9

HA 5 μg/ml

0.6

1.1

0.4

1.0

0.9

1.2

0.6

1.1

1.0

1.0

0.6

1.0

1.4

0.8

0.9

HA 0.5 μg/ml

0.8

1.2

0.4

1.0

1.1

0.8

0.9

1.2

0.4

0.9

0.7

1.0

1.4

0.9

1.1

HM 10 μg/ml

0.6

0.8

0.3

0.6

0.2

0.9

0.5

0.1

0.8

0.9

0.7

0.8

0.7

0.4

0.4

HM 5 μg/ml

0.6

1.0

0.4

1.2

0.8

1.2

0.8

0.7

0.9

1.1

0.9

1.3

1.1

0.5

0.9

HM 0.5 μg/ml

0.8

1.1

0.4

1.3

1.2

1.0

0.9

1.0

1.0

1.1

0.8

1.3

1.4

0.6

1.1

HP 10 μg/ml

0.5

0.3

0.1

0.4

n.d.

0.4

0.4

n.d.

0.1

0.3

0.1

n.d.

0.4

0.1

0.1

HP 5 μg/ml

0.7

0.6

0.4

0.5

0.0

0.9

0.7

0.0

0.2

0.8

0.4

0.6

0.5

0.2

0.3

HP 0.5 μg/ml

0.8

0.9

0.3

1.3

0.7

1.1

1.1

1.3

1.3

0.9

0.9

1.2

1.0

0.6

1.0

  1. D1, D2, D3, D4, D5: donor 1 to donor 5;
  2. Positive controls (PC): 50 μM omeprazole (1A2); 1 mM phenobarbital (2B6, 2C9); 100 mM ethanol (2E1); 10 μM rifampicine (3A4);
  3. n.d. not detectable